EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Smallpox vaccination‐elicited antibodies cross‐neutralize 2022‐Monkeypox virus Clade II

Elena Criscuolo iD, Benedetta Giuliani iD, Roberto Ferrarese iD, Davide Ferrari iD, Massimo Locatelli, Massimo Clementi, Nicasio Mancini iD, Nicola Clementi iD

Journal of Medical Virology · 2023-03 · 95 (3)

DOI: 10.1002/jmv.28643 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, online erschienen am 15.03.2023. Verfasst von Elena Criscuolo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Microbiology and Virology, Vita-Salute San Raffaele University, Milan, Italy. Hauptthemen laut MEDLINE: Mpox, Monkeypox, Smallpox, Smallpox Vaccine. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since early May 2022, some monkeypox virus (MPXV) infections have been reported from countries where the disease is not endemic. Within 2 months, the number of patients has increased extensively, becoming the most considerable MPXV outbreak described. Smallpox vaccines demonstrated high efficacy against MPXVs in the past and are considered a crucial outbreak control measure. However, viruses isolated during the current outbreak carry distinct genetic variations, and the cross‐neutralizing capability of antibodies remains to be assessed. Here we report that serum antibodies elicited by first‐generation smallpox vaccines can neutralize the current MPXV more than 40 years after vaccine administration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mpox, MonkeypoxSmallpoxSmallpox VaccineHumansMonkeypox virusVaccination

Stichwörter der Autor:innen

immunitymonkeypoxneutralizing antibodiesvaccinesvaccinia virus

Substanzen

Smallpox Vaccine

Autor:innen und Institutionen

  • Laboratory of Microbiology and Virology, Vita-Salute San Raffaele University, Milan, Italy.
  • SCVSA Department, University of Parma, Parma, Italy.
  • IRCCS San Raffaele Hospital, Milan, Italy.
  • Synlab Italia, Castenedolo (BS), Italy.

ORCID-Profile: Elena Criscuolo, Benedetta Giuliani, Roberto Ferrarese, Davide Ferrari, Nicasio Mancini, Nicola Clementi

Zitieren

APA

Criscuolo, E., Giuliani, B., Ferrarese, R., Ferrari, D., Locatelli, M., Clementi, M., Mancini, N., & Clementi, N. (2023). Smallpox vaccination‐elicited antibodies cross‐neutralize 2022‐Monkeypox virus Clade II. Journal of Medical Virology, 95(3). https://doi.org/10.1002/jmv.28643

Vancouver

Criscuolo E, Giuliani B, Ferrarese R, Ferrari D, Locatelli M, Clementi M, et al. Smallpox vaccination‐elicited antibodies cross‐neutralize 2022‐Monkeypox virus Clade II. Journal of Medical Virology. 2023;95(3). doi:10.1002/jmv.28643

BibTeX
@article{Criscuolo2023,
  author = {Criscuolo, Elena and Giuliani, Benedetta and Ferrarese, Roberto and Ferrari, Davide and Locatelli, Massimo and Clementi, Massimo and Mancini, Nicasio and Clementi, Nicola},
  title = {Smallpox vaccination‐elicited antibodies cross‐neutralize 2022‐Monkeypox virus Clade II},
  journal = {Journal of Medical Virology},
  year = {2023},
  volume = {95},
  number = {3},
  doi = {10.1002/jmv.28643}
}
Kostenlos starten →